Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus

Cell therapy is a progressively growing field that is rapidly moving from preclinical model development to clinical application. Outcomes obtained from clinical trials reveal the therapeutic potential of stem cell-based therapy to deal with unmet medical treatment needs for several disorders with no...

Full description

Bibliographic Details
Main Authors: Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, Yolanda Aguilera, Lucía Llanos, Juan R. Tejedo, Francisco J. Bedoya, Verónica Juan, Antonio De la Cuesta, Rafael Ruiz-Salmerón, Enrique Andreu, Lukas Grochowicz, Felipe Prósper, Fermín Sánchez-Guijo, Francisco S. Lozano, Manuel Miralles, Lourdes Del Río-Solá, Gregorio Castellanos, José M. Moraleda, Robert Sackstein, Mariano García-Arranz, Damián García-Olmo, Franz Martín, Abdelkrim Hmadcha, Bernat Soria, Collaborative Working Group “Noma Project Team”
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Immunology
Subjects:
cellular medicaments
cell-based therapy
clinical trials
diabetes
critical limb ischemia
cost-effective
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01151/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01151/full

Similar Items